Dr. Jiangbing Zhou, Nixdorff-German Professor of Neurosurgery and Biomedical Engineering, directs a multidisciplinary laboratory with a central focus on the development of translational nanomedicine, gene therapy, and stem cell therapy for treatment of neurological disorders.
Olivia Turk is a PhD candidate in the Biomedical Engineering department. She is co-advised by Dr. James Hansen and Dr. Jiangbing Zhou. Her research is focused on discovering ways to redesign and deploy cell-penetrating SLE autoantibodies as novel bioengineering reagents for the therapy of malignant and non-malignant diseases, including a novel anti-DNA antibody-gold nanoparticle approach to enhance the efficacy and safety of laser interstitial thermal therapy (LITT) in the management of brain tumors and/or radiation necrosis.